On 4 April 2019, Medacta Group SA, a pure play orthopaedics company, opened the IPO-season 2019 at SIX Swiss Exchange with the first day of trading of its shares. The shares of Medacta were priced at CHF 96.00 per share and on 3 May 2019, Medacta announced that the Joint Global Coordinators (Credit Suisse and Morgan Stanley) have partially exercised the over-allotment option in the amount of 438,472 existing shares at the offer price.